WordPress.com



PUBLICATIONSSinha S, Vasudev MK, Taly AB, Arunodaya GR, Ravishankar S, Prasanth LK, Venugopal KS, Swamy HS. Wilson’s disease: Cranial MRI observations and clinical correlation in 74 patients From India. Neurology (USA) 2003; 60: 288-289.Sinha S, Taly AB, Prashanth LK, Arunodaya GR, Swamy HS. Successful pregnancies and abortions in symptomatic and asymptomatic Wilson's disease. J Neurol Sci 2004;217(1):37-40.Prashanth LK, Taly AB, Sinha S, Arunodaya GR, Swamy HS. Wilson's disease: diagnostic errors and clinical implications. J Neurol Neurosurg Psychiatry 2004;75(6):907-909Sinha S, Prashanth LK, Mahadevan A, Satish S, Ravishankar S, Arunodaya GR, et al. Co-occurrence of Wilson's disease and glioblastoma multiforme--is it a chance association? Clin Neuropathol 2004;23(5):241-244.Meenakshi-Sundaram S, Sinha S, Rao M, Prashanth LK, Arunodaya GR, Rao S, et al. Cardiac involvement in Wilson's disease--an electrocardiographic observation. J Assoc Physicians India 2004;52:294-296.Sinha S, Ravishankar S, Taly AB, Arunodaya GR, Prashanth LK, Vasudev MK. Wilson’s disease: A 31P and 1H MR spectroscopic study. Neurology 2004; 62(5): 539-540.Sinha S, Christopher R, Prashanth LK, Vidya N, Arunodaya G R, S Rao, Taly AB. Malonialdhyde levels in Wilson’s disease? Annals of Indian Academy of Neurology, 2004;7(4):507-510. Prashanth LK, Sinha S. Pupil. Chakravorty A(ed) In Neurophthalmology. Journal of Association of eastern India, Kolkata, 2004: 406-423. Sinha S, Christopher R, Arunodaya GR, Prashanth LK, Gopinath G, Swamy HS, et al. Is low serum tocopherol in Wilson's disease a significant symptom? J Neurol Sci 2005;228(2):121-123.Prashanth LK, Taly AB, Sinha S, Ravishankar S, Arunodaya GR, Vasudev MK, et al. Prognostic factors in patients presenting with severe neurological forms of Wilson's disease. QJM 2005;98(8):557-563. Prashanth LK, Taly AB, Sinha S, Arunodaya GR, Swamy HS. Wilson’s disease: Diagnostic errors and clinical implications. Psychiatric review 2005; 5: 91-93.Prashanth LK, Taly AB, Ravi V, Sinha S, Arunodaya GR. Adult onset subacute sclerosing panencephalitis: clinical profile of 39 patients from a tertiary care centre. J Neurol Neurosurg Psychiatry 2006;77(5):630-633.Prashanth LK, Taly AB, Ravi V, Sinha S, Rao S. Long term survival in subacute sclerosing panencephalitis: an enigma. Brain Dev 2006;28(7):447-452.Sinha S, Taly AB, Ravishankar S, Prashanth LK, Venugopal KS, Arunodaya GR, et al. Wilson's disease: cranial MRI observations and clinical correlation. Neuroradiology 2006;48(9):613-621.Prashanth LK, Taly AB, Sinha S, Ravi V. Subacute sclerosing panencephalitis (SSPE): an insight into the diagnostic errors from a tertiary care university hospital. J Child Neurol 2007;22(6):683-688.Sinha S, Taly AB, Prashanth LK, Ravishankar S, Arunodaya GR, Vasudev MK. Sequential MRI changes in Wilson's disease with de-coppering therapy: a study of 50 patients. Br J Radiol 2007;80:744-749.Sinha S, Taly AB, Ravishankar S, Prashanth LK, Vasudev MK. Central Pontine Signal Changes in Wilson Disease: Distinct MRI Morphology and Sequential Changes with De-Coppering Therapy. J of Neuroimaging. 2007; 17:286-291.Shanmugiah A, Sinha S, Taly AB, Prashanth LK, Tomar M, Arunodaya GR, Janardhana Reddy YC, Khanna S. Psychiatric Manifestations in Wilson’s disease: A Cross-Sectional Analysis. J Neuropsychiatry Clin Neurosci. 2008;20:81-85.Srinivas K, Sinha S, Taly AB, Prashanth LK, Arunodaya GR, Janardhana Reddy YC, S Khanna. Dominant psychiatric manifestations in Wilson’s disease: a diagnostic and therapeutic challenge! J Neurol Sci. 2008;266:104-108. Komal Kumar RN, Taly AB, Nair KPS, Sinha S, Prashanth LK, Vidya N, Arunodaya GR, Rao S. Quality of Life in Wilson’s disease. Annals of Indian Academy of Neurology. 2008;11:37-43.Prashanth LK, Veerendrakumar M, Gayathri N, Subbukrishna DK. How many motor unit potentials to sample in diagnostic needle EMG? Clinical Neurophysiology. 2009;120 (Suppl-1):S23-S24.Veerendrakumar M, Gayathri N, Subbukrishna DK, Prashanth LK. Manual Scannin EMG study of variability of motor unit potential parameters. Clinical Neurophysiology. 2009;120 (Suppl-1):S40.Taly AB, Prashanth LK, Sinha S. Wilson's disease: An Indian perspective. Neurol India. 2009 Sep-Oct;57(5):528-40.Prashanth LK, Sinha S, Taly AB, A Mahadevan, Vasudev MK, Shankar SK. Spectrum of epilepsy in Wilson's disease with electroencephalographic, MR imaging and pathological correlates. J Neurol Sci. 2010 Apr 15;291(1-2):44-51.Sinha S, Taly AB, Ravishankar S, Prashanth LK, Vasudev MK. Wilson's disease: (31)P and (1)H MR spectroscopy and clinical correlation. Neuroradiology. 2010 Feb 20. [Epub ahead of print].Prashanth LK, Sinha S, Taly AB, Vasudev MK. Do MRI features distinguish Wilson's disease from other early onset extrapyramidal disorders? An analysis of 100 cases. Mov Disord. 2010 Apr 30;25(6):672-8.Prashanth LK, Fox S, Meissner WG. l-Dopa-induced dyskinesia-clinical presentation, genetics, and treatment. Int Rev Neurobiol. 2011;98:31-54.Lang AE, Prashanth LK, Ghosh S, Elahi B, Chen R. Extreme task specificity: is it dystonia or another form of motor programming abnormality? Mov Disord. 2012 Aug;27(9):1202-1203.Pondal M, Marras C, Miyasaki J, Moro E, Armstrong MJ, Strafella AP, Shah BB, Fox S, Prashanth LK, Phielipp N, Lang AE. Clinical features of dopamine agonist withdrawal syndrome in a movement disorders clinic. J Neurol Neurosurg Psychiatry. 2013;84(2):130-135.Fasano A, Valadas A, Bhatia KP, Prashanth LK, Lang AE, Munhoz RP, Morgante F, Tarsy D, Duker AP, Girlanda P, Bentivoglio AR, Espay AJ. Psychogenic facial movement disorders: clinical features and associated conditions. Mov Disord. 2012 Oct;27(12):1544-51.Connolly BS, Prashanth LK, Shah BB, Marras C, Lang AE. A randomized trial of varenicline (chantix) for the treatment of spinocerebellar ataxia type 3. Neurology. 2012 Nov 27;79(22):2218Petrovic IN, Ling H, Asi Y, Ahmed Z,?Kukkle PL, Hazrati LN, Lang AE, Revesz T, Holton JL, Lees AJ. Multiple system atrophy-parkinsonism with slow progression and prolonged survival: a diagnostic catch. Mov Disord. 2012 Aug;27(9):1186-90.Chan HF,?Kukkle PL, Merello M, Lim SY, Poon YY, Moro E. Amantadine improves gait in PD patients with STN stimulation. Parkinsonism Relat Disord. 2013 Mar;19(3):316-9. Ramana Reddy AM,?Prashanth LK, Sharat Kumar GG, Chandana G, Jadav R. Over-the-counter self-medication leading to intracranial hypertension in a young lady. J Neurosci Rural Pract. 2014 Oct;5(4):384-6. Ling H, Asi YT, Petrovic IN, Ahmed Z,?Prashanth LK, Hazrati LN, Nishizawa M, Ozawa T, Lang A, Lees AJ, Revesz T, Holton JL. Minimal change multiple system atrophy: An aggressive variant? Mov Disord. 2015 Apr 8. doi: 10.1002/mds.26220. [Epub ahead of print]Prashanth LK, Murugan S, Kamath V, Gupta R, Jadav R, Sreekantaswamy S, Ramprasad VL. First report of Kufor-Rakeb Syndrome (PARK 9) from India, and a Novel Nonsense Mutation in ATP13A2 gene. ................
................

In order to avoid copyright disputes, this page is only a partial summary.

Google Online Preview   Download